Tuesday, July 29, 2014

Compounded Drugs of Value in Outpatient Hospice Care--A Part of LMHPCO Seminar

C 3 Compounded Drugs of Value

in Outpatient Hospice Care


John P. “Jack” McNulty, MD, FACP, FAAHPM

Founder

Palliative Care Institute of Southeast Louisiana


George B. Muller, BS in Pharm., R.Ph

Owner

Muller Compounding Consultants LLC d/b/a

Compounding Business Services

A compounded preparation is needed when

no commercially manufactured medication is

available to adequately address a patient’s

medical needs. Among the greatest therapeutic

challenges faced by both patients and caregivers

is the treatment required by individuals who

have a terminal condition. It is difficult to find

evidence-based studies on the management

of end-of-life situations because each patient’s

medical case is unique. In addition, maintaining

a controlled environment for such patients is

difficult. End-of-life care is multifaceted; it does

not lend itself to “cookbook medicine,” and

people with a terminal illness are among the

most vulnerable patients in need of effective and

compassionate care. When those patients suffer

in spite of commercially available therapies,

the innovation and experience of clinicians

and compounding pharmacists can often yield

a solution to the most challenging treatment

problems. In this presentation, we discuss some

of the most often prescribed compounds used

in outpatient hospice and palliative care to

treat common conditions (wounds, pain and

dyspnea, intractable cough, nausea and vomiting,

depression, bladder infections caused by an

indwelling catheter, rectal pain). The effectiveness

of the preparations we describe is substantiated

in the medical literature and by our personal

experience, which together encompasses nearly

100 years of clinical practice. The medications

described in this report have been shown over

time to be effective.



quoted from here

No comments: